Jacqui O’Connor | Meet the Speakers: Med-Tech Expo 2026

Key Takeaways

• Jacqui O’Connor leads MedScan3D, a 3‑D anatomical modeling pioneer
• Speaker slot: Innovation Stage, June 3, 1:30‑1:50 PM at Med‑Tech Expo
• Focus on accelerating brain‑computer interface therapy development
• Free event pass available via registration link
• MintNeuro‑Motif Neurotech partnership underscores neuro‑tech momentum

Pulse Analysis

The Med‑Tech Expo 2026 continues to be a bellwether for emerging technologies that bridge the gap between research and patient care. Jacqui O’Connor’s upcoming session spotlights MedScan3D’s cutting‑edge anatomical modeling platform, which leverages high‑resolution imaging and AI‑driven mesh generation to create patient‑specific virtual replicas. By compressing the traditionally lengthy design‑validation loop, manufacturers can iterate device prototypes in silico, reducing reliance on costly animal studies and expediting regulatory submissions. This shift is especially critical for brain‑computer interface (BCI) therapies, where precise fit and safety are non‑negotiable.

Beyond the technical advantages, O’Connor’s talk underscores a broader industry trend: the convergence of simulation, digital twins, and personalized medicine. As MintNeuro teams up with Motif Neurotech to deliver miniature BCI solutions for mental‑health disorders, the demand for accurate anatomical models skyrockets. Real‑time simulation enables clinicians to predict neural interaction outcomes before implantation, fostering confidence among investors and regulators alike. The partnership exemplifies how collaborative ecosystems accelerate innovation, turning once‑theoretical concepts into viable clinical products.

For stakeholders—from venture capitalists to hospital procurement officers—the implications are clear. Faster development cycles translate to earlier market entry, competitive differentiation, and ultimately, improved patient outcomes. Attendees of the Expo can expect actionable insights on integrating 3‑D modeling into their product pipelines, navigating FDA pathways for digital health devices, and leveraging data‑driven design to meet the growing appetite for neuro‑tech solutions. As the med‑tech landscape evolves, mastering these tools will be essential for staying ahead of the curve.